ScholarIQanswers from OpenAlex

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines

PaperCitations, authors & open-access status

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines have?

ScholarIQcitation count

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines has 83 citations in the OpenAlex counts ScholarIQ stores.

When was Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines published?

ScholarIQyear

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines has 2009 year in the ScholarIQ index.

What is the open-access status of Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines?

ScholarIQoa status

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines has green oa status in the ScholarIQ index.

What is the DOI of Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines?

ScholarIQdoi

The DOI for Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines is on the source record.

What is the PMID of Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines?

ScholarIQpmid

The PMID for Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines is on the source record.

What is the OpenAlex record for Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines?

ScholarIQopenalex

The OpenAlex for Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial